Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Dinesh Thakur

    Jump to

    • Pharma whistleblower: Consumers must question medicines' quality

    • SC declines lawsuits against drug regulators: Activist

    • Pharma crusader Thakur takes India's drug regulators to court

    • Cannot comment on charges against Ranbaxy: Thakur

      Dinesh Thakur, the Ranbaxy whistleblower, says he have no basis to comment on Daiichi Sankyo's decision to sue the Singh family for concealment and misrepresentation of data, as he left the company in 2005.

    • Malvinder Singh denies Daiichi's charges of wrongdoing

      CNBC-TV18 executive editor Shereen Bhan and Archana Shukla reports that Malvinder Singh, while denying all wrong-doing at Ranbaxy, says that Daiichi took months to clinch the deal and the due diligence process was rigourously followed.

    • Ranbaxy whistleblower pockets $48.5mn for settlement

      CNBC-TV18‘s Archana Shukla takes a closer look at Dinesh Thakur, the man who blew the whistle on Ranbaxy, and kicked off a legal battle that other generic drug makers will take notes from

    • Ranbaxy whistleblower Thakur richer by Rs 266cr; speaks out

      Dinesh Thakur served as the whistleblower in this case and is the former Ranbaxy Director and Global Head, Research Information & Portfolio Management. Thakur is entitled to Rs 266 crore as the whistleblower in the case, the US Justice Department said.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347